New Cholesterol Pill Could Help Prevent Heart Attacks
Scientists have recently tested an experimental oral pill that dramatically lowers LDL “bad” cholesterol in people at high risk for heart disease. In a large clinical trial, this new drug reduced LDL levels by up to 60%, showing stronger effects than many currently available cholesterol-lowering treatments. Early results suggest it could become a convenient alternative to injectable therapies if further studies confirm its long-term safety and ability to reduce heart attacks and strokes. This development offers hope for millions who struggle to control cholesterol despite existing medications.
5 Likes
Yes,recent study shows ,that good effect of pill to reduce bad cholesterol.
This cholesterol pill has successfully completed Phase-3 trials,by showing 55-60% reduction in bad cholesterol levels.
But, required review and regulatory decisions and approvals are still pending in major markets like USA,Europe and India.
This pill is designed for the patients who can not reach their cholesterol goal with statin treatment only or those who have high risk heart disease.
Still it’s not available in the market for general use but very soon it will be available in market so that we can get more data on efficacy of that pill and other side effects.
After final testing it should be available in market as there r many people facing this bad cholesterol issue.
“What a promising breakthrough in preventing cardiovascular diseases!
A 60% reduction in low-density lipids, or bad cholesterol, is highly promising and could actually be life-changing to many high-risk patients who have not been responding very well to existing treatments and interventions. Moreover, the ease and convenience of taking an oral medication rather than injectable medication options are definitely advantageous and can enhance compliance. If it really works in preventing heart attacks and strokes, then this could indeed be a game-changer for millions of people battling high uncontrollable cholesterol levels.”
That said, the real milestone will be long term safety and hard endpoint data: actual reduction in heart attacks and strokes, not just LDL numbers. If those results hold up, this pill could significantly expand our preventive cardiology toolkit and improve access for millions.
Well, that is a promising information. If proven safe it be a boon to hypercholestraemia patient.